Complementing the Cancer-Immunity Cycle-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Complementing the Cancer-Immunity Cycle

Published:2019-04-12 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Pio Ruben,Ajona Daniel,Ortiz-Espinosa Sergio,Mantovani Alberto,Lambris John D.

Funder

Fundación Científica Asociación Española Contra el Cáncer

Fundación Ramón Areces

Instituto de Salud Carlos III

National Institutes of Health

Associazione Italiana per la Ricerca sul Cancro

Ministero della Salute

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference145 articles.

1. Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines;Lohmueller;Pharmacol Ther.,2017

2. Molecular pathways: coexpression of immune checkpoint molecules: signaling pathways and implications for cancer immunotherapy;Nirschl;Clin Cancer Res.,2013

3. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations;Zou;Sci Transl Med.,2016

4. PDL1 signals through conserved sequence motifs to overcome interferon-mediated cytotoxicity;Gato-Cañas;Cell Rep.,2017

5. The intracellular signalosome of PD-L1 in cancer cells;Escors;Signal Transduct Target Ther.,2018

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The battle within: cell death by phagocytosis in cancer;Clinical and Translational Oncology;2024-08-21

2. Identification and immunoassay of prognostic genes associated with the complement system in acute myeloid leukemia;Journal of the Formosan Medical Association;2024-08

3. Complement factor I knockdown inhibits colon cancer development by affecting Wnt/β-catenin/c-Myc signaling pathway and glycolysis;World Journal of Gastrointestinal Oncology;2024-06-15

4. Thymoquinone affects hypoxia-inducible factor-1α expression in pancreatic cancer cells via HSP90 and PI3K/AKT/mTOR pathways;World Journal of Gastroenterology;2024-06-07

5. Glyco-signatures in patients with advanced lung cancer during anti-PD-1/PD-L1 immunotherapy;Acta Biochimica et Biophysica Sinica;2024-06-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3